Mayne Pharma reported $1.24B in Ordinary Share Capital for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Ansell ANN:AU $ 758.7M 10.3M
Cochlear COH:AU $ 1.28B 0
Ecofibre Ltd EOF:AU 114.82M 6.69M
Healius Ltd HLS:AU $ 2.46B 114.3M
Integral Diagnostics Ltd IDX:AU 234.53M 15.31M
Nanosonics Ltd NAN:AU $ 113.71M 168K
Next Science Ltd NXS:AU 102.92M 0
Polynovo Ltd PNV:AU 139.25M 180K
Probiotec Ltd PBP:AU 50.69M 0
Ramsay Health Care RHC:AU $ 2.2B 0
ResMed RMD:AU $ 585K 0
Sigma Healthcare Ltd SIG:AU 1.23B 3.53M
Sonic Healthcare SHL:AU $ 4.14B 61.89M
Telix Pharmaceuticals Ltd TLX:AU 170.84M 2.93M